Novab, Inc.
Antibody polymer diagnostic reagents for rapid SARS-CoV-2 antigen detection using engineered variable lymphocyte receptor (VLR) polymers
- Sector
- Medtech
- Headquarters
- Tucker, GA
- Founded
- 2013
- Latest Form D
- $65K, Apr 2026
- Total capital
- $2.6M
- Federal grants
- $1.1M
- 5 awards · 2015–2023
- Rank in peer group#28 of 30
- Private capital raised
- $1.6M
- 9 Form D · last Apr 2026
- 6 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 9th filing$65K
- Private capital raisedForm D · SEC · 8th filing$50K
- Private capital raisedForm D · SEC · 7th filing$210K
- Private capital raisedForm D · SEC · 6th filing$250K
- Private capital raisedForm D · SEC · 5th filing$125K
- Federal grantHealth and Human S · Phase I · Novel targeted CAR-T multiple myeloma therapy$302K
- Private capital raisedForm D · SEC · 4th filing$250K
- Private capital raisedForm D · SEC · 3rd filing$300K
- Private capital raisedForm D · SEC · 2nd filing$300K
- Offering registeredForm D · SEC · 1st filing$600K
Show 4 earlier federal awards
- Federal grantHealth and Human S · Phase I · Novel antibody polymer reagents for SARS-CoV-2 detection$257K
- Federal grantHealth and Human S · Phase I · Monoclonal antibodies specific for biologically relevant glycans$223K
- Federal grantHealth and Human S · Phase I · Monoclonal lamprey VLR antibodies specific for mucin-type O-linked glycan core 1 - 4 structures$136K
- Federal grantHealth and Human S · Phase I · Humanization of VLR antibodies for therapeutic applications$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
20months
from Novab, Inc.’s first federal award to its first private round.
- First federal award · Jan 2015
- Health and Human S · $150K
- First Form D · Sep 2016
- $600K · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 30 peers
Line = medianMedtech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Lovick Edward CannonResearcherExecutive Officer, DirectorLinked by $257K in grants as PI
- Greg DaneDirectorNamed in SEC Form D filings
- Gregory Edward DaneDirectorNamed in SEC Form D filings
- L. Edward CannonExecutive Officer, DirectorNamed in SEC Form D filings
- Max D. CooperDirectorNamed in SEC Form D filings
- Thomas Chris CannonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingEngineered Vlrb Antibodies With Immune Effector FunctionsUSPTOApplication 18293242
- PendingMultivalent Glycan Scaffolds And Methods Of Use ThereofUSPTOApplication 18686779
- PendingMultivalent Glycan Scaffolds And Methods Of Use ThereofUSPTOApplication PCTUS2022075446
Show all 6 patent records
- Engineered Vlrb Antibodies With Immune Effector FunctionsMay 22, 2025 · Application 18293242Pending
- Multivalent Glycan Scaffolds And Methods Of Use ThereofNov 7, 2024 · Application 18686779Pending
- Multivalent Glycan Scaffolds And Methods Of Use ThereofApplication PCTUS2022075446Pending
- Engineered Vlrb Antibodies With Immune Effector FunctionsApplication PCTUS2022074225Pending
- Multivalent Glycan Scaffolds And Methods Of Use ThereofApplication 63237068Pending
- Engineered Vlrb Antibodies With Immune Effector FunctionsApplication 63203616Pending
Related companies, and why
- Happy Medium Development Ltd Liability CoSimilar federal contract value in Medtech · null in contracts
- SHAPE MEDICAL SYSTEMS, INC.Similar federal contract value in Medtech · null in contracts
- Enspectra Health, Inc.Similar federal contract value in Medtech · null in contracts
- VERAVANTI INC.Similar federal contract value in Medtech · null in contracts
- Intabio, Inc.Similar federal contract value in Medtech · null in contracts
- Injectsense, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .